# ClearSight NextGen1 Study

> **NCT07317648** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 35 (actual)

## Conditions studied

- Blood Pressure

## Interventions

- **DEVICE:** ClearSight NextGen system

## Key facts

- **NCT ID:** NCT07317648
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-16
- **Primary completion:** 2026-03-05
- **Final completion:** 2026-03-05
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07317648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07317648, "ClearSight NextGen1 Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07317648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*